In addition, p16—a CDKI closely related to the HPV 16 status frequently seen in head and neck cancers—is typically downregulated in tumors with high cyclin D1, and its presence tends to indicate better treatment response and survival [164]. Here, CCND1 is linked to head and neck cancer.